15.03.2012 • NewsappointmentEli LillyGuy Villax

Hovione Announces Appointment of Colin Minchom as Vice President, Particle Design Business Unit

Hovione announced the appointment of Dr. Colin Minchom as Vice President of its Particle Design Business Unit. Dr. Minchom was most recently with Patheon where he held the position of Vice President, Pharmaceutical Development Services for North America. Based in East Windsor, New Jersey, Dr. Minchom will report to Guy Villax, Hovione's Chief Executive Officer.

Dr. Minchom's 29-year career includes extensive experience in the process, science and global regulation of drug development with emphasis on dosage forms and drug delivery. Prior to this role at Patheon Dr. Minchom was Head of Pharmaceutical Sciences at Cerebrus, a UK privately held pharmaceutical company and has also held positions of increasing scientific and management responsibility at Eli Lilly and E.R. Squibb in formulation and product development, project management and product management.

 

Company

Hovione

Sete Casas
2674-506 Loures
Portugal

Company contact







Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.